MUSTANG BIO INC's ticker is MBIO and the CUSIP is 62818Q104. A total of 80 filers reported holding MUSTANG BIO INC in Q3 2020. The put-call ratio across all filers is 2.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $99,000 | +98.0% | 59,622 | +219.9% | 0.00% | – |
| Q3 2021 | $50,000 | +38.9% | 18,635 | +71.8% | 0.00% | – |
| Q2 2021 | $36,000 | -21.7% | 10,850 | -22.2% | 0.00% | – |
| Q1 2021 | $46,000 | -4.2% | 13,953 | +10.3% | 0.00% | – |
| Q4 2020 | $48,000 | +29.7% | 12,654 | +6.4% | 0.00% | – |
| Q3 2020 | $37,000 | -21.3% | 11,898 | -19.7% | 0.00% | – |
| Q2 2020 | $47,000 | +23.7% | 14,812 | +5.0% | 0.00% | – |
| Q1 2020 | $38,000 | -49.3% | 14,100 | -23.7% | 0.00% | – |
| Q4 2019 | $75,000 | +17.2% | 18,468 | -5.7% | 0.00% | – |
| Q3 2019 | $64,000 | -35.4% | 19,594 | -27.5% | 0.00% | – |
| Q2 2019 | $99,000 | +67.8% | 27,038 | +57.4% | 0.00% | – |
| Q1 2019 | $59,000 | +22.9% | 17,183 | +6.3% | 0.00% | – |
| Q4 2018 | $48,000 | -59.7% | 16,163 | -18.9% | 0.00% | – |
| Q3 2018 | $119,000 | -31.2% | 19,930 | -20.5% | 0.00% | – |
| Q2 2018 | $173,000 | – | 25,073 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 297,500 | $300,000 | 0.47% |
| GSA CAPITAL PARTNERS LLP | 1,216,445 | $1,229,000 | 0.16% |
| Ikarian Capital, LLC | 546,824 | $551,000 | 0.07% |
| Sassicaia Capital Advisers LLC | 12,000 | $12,000 | 0.06% |
| EMFO, LLC | 32,000 | $32,000 | 0.03% |
| B. Riley Wealth Advisors, Inc. | 310,926 | $315,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 312,800 | $316,000 | 0.01% |
| Renaissance Technologies | 2,449,100 | $2,474,000 | 0.00% |
| Arete Wealth Advisors, LLC | 15,538 | $16,000 | 0.00% |
| Herold Advisors, Inc. | 4,000 | $4,040,000 | 0.00% |